Skip to main content
. 2023 Aug 14;13(12):4715–4732. doi: 10.1016/j.apsb.2023.08.010

Figure 21.

Figure 21

Construction of heterogeneous multivalent inhibitors based on erythrocyte membrane and their interaction with IFV.